SINGLE SIROLIMUS VERSUS PACLITAXEL ELUTING STENT IMPLANTATION WITH KISSING BALLOON TECHNIQUE IN THE TREATMENT OF NON-LEFT MAIN BIFURCATION.  by Yamawaki, Masahiro et al.
    
 i2 SUMMIT   
A199.E1874 
JACC March 9, 2010
Volume 55, issue 10A
SINGLE SIROLIMUS VERSUS PACLITAXEL ELUTING STENT IMPLANTATION WITH KISSING BALLOON 
TECHNIQUE IN THE TREATMENT OF NON-LEFT MAIN BIFURCATION.
i2 Poster Contributions
Georgia World Congress Center, Hall B5
Monday, March 15, 2010, 9:30 a.m.-10:30 a.m.
Session Title: Intravascular Diagnostics and Complex Lesions
Abstract Category: PCI - Bifurcations
Presentation Number: 2503-431
Authors: Masahiro Yamawaki, Toshiya Muramatsu, Reiko Tsukahara, Yoshiaki Ito, Tsuyoshi Sakai, Hiroshi Ishimori, Keisuke Hirano, Masatsugu 
Nakano, Shinya Sasaki, Motoharu Araki, Akiyoshi Moriyama, Hideyuki Takimura, Yasunari Sakamoto, Ikki Komatsu, Saiseikai Yokohama city eastern 
hospital, Yokohama, Japan
Background: Bifurcated lesions remain challenging lesions, and restenosis at side branch (SB) ostium continues to be a problem even in 
drug-eluting stent (DES) era. Single stenting in main vessel (MV) with final kissing balloon technique (single-stent-FKBT) is accepted strategy for 
bifurcation. In daily practice using this strategy, we compared the efficacy of Sirolimus eluting stent (SES) with that of Paclitaxel eluting stent (PES), 
and investigate predictor of angiographic restenosis at side branch ostium in 8 months. 
Method: Of 2424 patients treated with DES between May 2004 and Feb 2009, consective 141 patients (148 non-left main bifurcations) who 
underwent single-stent-FKBT (SES-group) were compared to 104 patients (113 non-left main bifurcations) treated with same strategy (PES-group). 
Result: There was no difference in patient, lesion characteristics and pre-/post-procedure QCA analysis. No difference was also seen in the 
incidence of stent thrombosis or cardiac death in hospital between two groups. After 8 months, either MLD or percent diameter stenosis (%DS) 
revealed SES group was superior to PES group in MV(MLD: 2.4±0.6mm vs. 2.0±0.6mm; p<0.01, %DS: 14.9±17.2% vs. 22.9±18.7%; p<0.01)as well 
as SB(MLD: 1.6±0.6mm vs. 1.3±0.6mm; p<0.05, %DS: 32.8±21.8% vs. 42.9±26.5% ; p<0.01). Regarding binary restenosis, SES group was lower 
than PES group in both MB(4% vs. 13%;p<0.05) and SB(18% vs. 41%; p<0.01).
Logistic regression analysis revealed the predictor for angiographic restenosis at SB ostium were PES(OR 4.40; 95%CI1.67-11.6;p<0.01),Diabetes 
mellitus(OR2.74; 95%CI 1.06-7.06; p<0.05), and balloon to artery ratio at SB (OR 0.05; 95%CI 0.00-0.70:p<0.05). However, no difference was seen 
in clinically-driven TLR (SES vs. PES; 2.7% vs. 7.7%) and MACE (4.7% vs. 11.5%) between two groups.
Conclusion: In the setting of single-stent-FKBT for bifurcated lesion, sirolimus- was more effective than paclitaxel eluting stent in terms of 
angiographic restenosis. Predictor of SB restenosis was PES, Diabetes mellitus and balloon to artery ratio at SB. However, regarding clinically-driven 
TLR or MACE, no difference was seen between SES and PES in this strategy.
